Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

UnitedHealth (UNH) warned rising medical costs will weigh on 2025 earnings with a record-high medical loss ratio, driven by Medicare and outpatient care. Yahoo Finance Senior Reporter Anjalee Khemlani ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an American telehealth company offering personal care products and online ...

Obesity drugmaker Novo Nordisk on Tuesday cut its full-year sales and operating profit forecasts for the second time this ...